UPMC Hillman Cancer Center - Radiation Oncology

Pittsburgh, Pennsylvania 15232

1 studies enrolling now · 5 studies all time

What they study most

Liver Metastases, Oligometastatic Disease, Previously-Irradiated, Recurrent Oligometastatic Disease, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Cancer

Studies at this site

• Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design — Recruiting now
• Stereotactic Body Radiation Therapy (SBRT) for Liver Mets — Completed
• Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation — Stopped early
• SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN — Completed
• Radiosurgery for Patients Recurrent Oligometastatic Disease — Completed